Amy Wesa - Email & Phone Number

Vice President Research And Development at Champions Oncology, Inc.

Amy Wesa is based out of Rockville, Maryland, United States and works at Champions Oncology, Inc. as Vice President Research And Development.

Amy Wesa's Contact Information

Amy Wesa's Work email

a*****@champi***.com

Valid

Latest update

October 12, 2025

Location

Rockville, Maryland, United States

Amy's current employer

Champions Oncology, Inc.

Description

Champions combines innovative technology and unrivaled expertise to enable more efficient drug discovery and development workflow.

Website

championsoncology.com

HQ Location

Hackensack, New Jersey, United States

Number of employees

51-200

Industry

Biotechnology Research

Latest update

May 1, 2024

Read about Champions Oncology, Inc.

Frequent questions about Amy Wesa

What company is Amy Wesa working for?

Amy Wesa works for Champions Oncology, Inc..

What is Amy Wesa's function at Champions Oncology, Inc.?

Amy Wesa is Vice President Research And Development at Champions Oncology, Inc..

Where is Amy Wesa based?

Amy Wesa is based out of Rockville, Maryland, United States.

What is Amy Wesa's work email address?

Amy Wesa's professional email address is a*****@champi***.com

Who are Amy Wesa's co-workers?

Amy Wesa's colleagues are Brady Davis, Ronnie Morris, David DeOrnellis, Marianna Zipeto, Karin Heidemann, Rachel Bunting, Kakajan Komurov, Mark Schonau, Alexandre Moreau, Taylor Muir, Jessica Rubin, Art Hanson, Vaishnavi Sambandam, Benjamin Zetts, Kamala Kesavan, Patrick Glaser, Sarah Maenhout, Samaneh Kamali, Franklin Lin, Veronica Zanon, Nektaria Papadopoulou, Louise Woolley, Chuanwen Lu, Sebastian Brabetz, Timothy McKinnon, Chelsea Riveley, Daniela Torres, Wendeline Wagner, Federica Paoli, Armelle Dishington, Frank Smith, Gacenta Bowen, Emilie Gross, Clare Killick-Cole.

Amy's co-workers

Executive Vice President, Global Laboratory Operations

Marianna Zipeto

Executive Vice President, Commercial

Karin Heidemann

Executive Vice President, Global Scientific Operations

Rachel Bunting

Vice President Global Marketing

Kakajan Komurov

Vice President and Head, Oncology Discovery

Mark Schonau

CFO

Alexandre Moreau

Vice President of Business Development West Coast/APAC & Global Partnerships

Taylor Muir

Study Coordinator I, Study Management

Jessica Rubin

Vice President, Accounting and Controller

Art Hanson

Vice President Of Technology

Vaishnavi Sambandam

Scientific Team Lead, Ex vivo

Benjamin Zetts

Facility Operations Team Lead

Kamala Kesavan

Director, Strategic Alliances and Partnerships

Patrick Glaser

Team Lead, Model Development and Characterization

Sarah Maenhout

Study Director

Samaneh Kamali

Scientific Project Lead, MPS

Franklin Lin

Study Director and Subject Matter Expert (Leukemia)

Veronica Zanon

Study Director

Nektaria Papadopoulou

Scientific Team Lead (UK/APAC)

Louise Woolley

Study Director

Chuanwen Lu

Head Of Clinical Operations

Sebastian Brabetz

Director, Business Development - Translational Oncology Solutions - Central Europe

Timothy McKinnon

Study Director

Chelsea Riveley

Head Of Business Development, Biomarker Services

Daniela Torres

Study Director

Wendeline Wagner

Senior Director of Laboratory Operations

Federica Paoli

Team Lead

Armelle Dishington

Director of Business Development Southern & western Europe

Frank Smith

Senior Director- Head of East Coast Business Development

Gacenta Bowen

Surgical Services Lead Tech

Emilie Gross

Director Of Business Development, Translational Immuno-Oncology Solution

Clare Killick-Cole

Associate Director, Business Development

Browse & Connect

Browse companies

Our company index contains hundreds of thousands of businesses.

a b c d e f g h i j k l m n o p q r s t u v w x y z

Wiza does not guarantee or claim any of the information found on this public directory to be 100% accurate or up to date.Information found here is gathered from a variety of online and offline sources.If you wish to exclude your personal data from this public directory please fill out the optout form.